| Year |
Citation |
Score |
| 2020 |
Compston A. Review: Multiple sclerosis in the digital age: 'seeing through a glass darkly'. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32709701 DOI: 10.1136/Jnnp-2020-323235 |
0.313 |
|
| 2020 |
Ban M, Liao W, Baker A, Compston A, Thorpe J, Molyneux P, Fraser M, Khadake J, Jones J, Coles A, Sawcer S. Transcript specific regulation of expression influences susceptibility to multiple sclerosis. European Journal of Human Genetics : Ejhg. PMID 31932686 DOI: 10.1038/S41431-019-0569-0 |
0.347 |
|
| 2018 |
Lehmann HC, Compston A, Hartung HP. 150th anniversary of clinical description of multiple sclerosis: Leopold Ordenstein's legacy. Neurology. 90: 1011-1016. PMID 29807916 DOI: 10.1212/Wnl.0000000000005613 |
0.315 |
|
| 2014 |
Compston A. Update on disease modifying therapies in MS. Multiple Sclerosis and Related Disorders. 3: 767. PMID 25891625 DOI: 10.1016/J.Msard.2014.09.014 |
0.337 |
|
| 2014 |
Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ, van Es M, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH, ... ... Compston A, et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Human Molecular Genetics. 23: 1916-22. PMID 24234648 DOI: 10.1093/Hmg/Ddt574 |
0.369 |
|
| 2013 |
Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Annals of Neurology. 73: 430-2. PMID 23444327 DOI: 10.1002/Ana.23833 |
0.332 |
|
| 2012 |
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. The Lancet. Neurology. 11: 150-6. PMID 22236384 DOI: 10.1016/S1474-4422(11)70305-2 |
0.327 |
|
| 2011 |
Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, ... ... Compston A, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology. 70: 897-912. PMID 22190364 DOI: 10.1002/Ana.22609 |
0.51 |
|
| 2011 |
Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, ... ... Compston A, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476: 214-9. PMID 21833088 DOI: 10.1038/Nature10251 |
0.367 |
|
| 2011 |
Zuvich RL, Bush WS, McCauley JL, Beecham AH, De Jager PL, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Sawcer SJ, Pericak-Vance MA, Barcellos LF, Mortlock DP, Haines JL. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. Human Molecular Genetics. 20: 3517-24. PMID 21653641 DOI: 10.1093/Hmg/Ddr250 |
0.366 |
|
| 2011 |
Connick P, Kolappan M, Patani R, Scott MA, Crawley C, He XL, Richardson K, Barber K, Webber DJ, Wheeler-Kingshott CA, Tozer DJ, Samson RS, Thomas DL, Du MQ, Luan SL, ... ... Compston A, et al. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. Trials. 12: 62. PMID 21366911 DOI: 10.1186/1745-6215-12-62 |
0.33 |
|
| 2011 |
Kemppinen A, Sawcer S, Compston A. Genome-wide association studies in multiple sclerosis: lessons and future prospects. Briefings in Functional Genomics. 10: 61-70. PMID 21310812 DOI: 10.1093/Bfgp/Elr004 |
0.368 |
|
| 2011 |
Compston A. Here there are lions Brain. 134: 3127-3134. DOI: 10.1093/Brain/Awr251 |
0.302 |
|
| 2010 |
Briggs FB, Bartlett SE, Goldstein BA, Wang J, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, et al. Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. Human Molecular Genetics. 19: 4286-95. PMID 20699326 DOI: 10.1093/Hmg/Ddq328 |
0.364 |
|
| 2010 |
Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, et al. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. Plos One. 5: e11296. PMID 20593013 DOI: 10.1371/Journal.Pone.0011296 |
0.328 |
|
| 2010 |
Briggs FB, Goldstein BA, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, Haines JL, Barcellos LF, et al. Variation within DNA repair pathway genes and risk of multiple sclerosis. American Journal of Epidemiology. 172: 217-24. PMID 20522537 DOI: 10.1093/Aje/Kwq086 |
0.349 |
|
| 2010 |
Somerfield J, Hill-Cawthorne GA, Lin A, Zandi MS, McCarthy C, Jones JL, Willcox M, Shaw D, Thompson SA, Compston AS, Hale G, Waldmann H, Coles AJ. A novel strategy to reduce the immunogenicity of biological therapies. Journal of Immunology (Baltimore, Md. : 1950). 185: 763-8. PMID 20519651 DOI: 10.4049/Jimmunol.1000422 |
0.563 |
|
| 2010 |
Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S, Vukcevic D, Barnes C, Conrad DF, Giannoulatou E, Holmes C, Marchini JL, Stirrups K, Tobin MD, ... ... Compston A, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 464: 713-20. PMID 20360734 DOI: 10.1038/Nature08979 |
0.318 |
|
| 2010 |
Anderson JM, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S. Abnormal tau phosphorylation in primary progressive multiple sclerosis. Acta Neuropathologica. 119: 591-600. PMID 20306268 DOI: 10.1007/S00401-010-0671-4 |
0.324 |
|
| 2010 |
Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Sawcer SJ, Pericak-Vance MA, Haines JL, Hauser SL, et al. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Human Molecular Genetics. 19: 2331-40. PMID 20211854 DOI: 10.1093/Hmg/Ddq101 |
0.326 |
|
| 2010 |
Zuvich RL, McCauley JL, Oksenberg JR, Sawcer SJ, De Jager PL, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston A, Hauser SL, Pericak-Vance MA, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Human Genetics. 127: 525-35. PMID 20112030 DOI: 10.1007/S00439-010-0789-4 |
0.356 |
|
| 2010 |
Compston A. 25. Aetiology and origins of multiple sclerosis Journal of Clinical Neuroscience. 17: 1617-1618. DOI: 10.1016/J.Jocn.2010.07.026 |
0.361 |
|
| 2009 |
Compston A. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509. Brain : a Journal of Neurology. 132: 1997-2001. PMID 19634211 DOI: 10.1093/Brain/Awp193 |
0.31 |
|
| 2009 |
De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, ... ... Compston A, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics. 41: 776-82. PMID 19525953 DOI: 10.1038/Ng.401 |
0.501 |
|
| 2009 |
Anderson JM, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S. Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis. Acta Neuropathologica. 117: 583-9. PMID 19288121 DOI: 10.1007/S00401-009-0515-2 |
0.329 |
|
| 2009 |
De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, ... ... Compston A, et al. The role of the CD58 locus in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 5264-9. PMID 19237575 DOI: 10.1073/Pnas.0813310106 |
0.314 |
|
| 2008 |
Hampton DW, Anderson J, Pryce G, Irvine KA, Giovannoni G, Fawcett JW, Compston A, Franklin RJ, Baker D, Chandran S. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. Journal of Neuroimmunology. 201: 200-11. PMID 18672298 DOI: 10.1016/J.Jneuroim.2008.05.034 |
0.343 |
|
| 2008 |
Chandran S, Hunt D, Joannides A, Zhao C, Compston A, Franklin RJ. Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 363: 171-83. PMID 17282989 DOI: 10.1098/Rstb.2006.2019 |
0.324 |
|
| 2008 |
Compston A. The problem of disseminated sclerosis (being the Presidential Address of the Neurological Section, Royal Society of Medicine, October 1946). By Douglas McAlpine. Brain 1946: 69; 233–250. Brain. 131: 1677-1680. DOI: 10.1093/Brain/Awn130 |
0.373 |
|
| 2007 |
Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, ... ... Compston A, ... ... Compston A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics. 39: 1329-37. PMID 17952073 DOI: 10.1038/Ng.2007.17 |
0.347 |
|
| 2007 |
Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. The New England Journal of Medicine. 357: 851-62. PMID 17660530 DOI: 10.1056/Nejmoa073493 |
0.326 |
|
| 2007 |
Compston A. Complexity and heterogeneity in demyelinating disease. Brain : a Journal of Neurology. 130: 1178-80. PMID 17472981 DOI: 10.1093/Brain/Awm092 |
0.331 |
|
| 2007 |
Ban M, Walton A, Goris A, Gray J, Compston A, Sawcer S. Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis. Journal of Neurology. 254: 398-9. PMID 17345035 DOI: 10.1007/S00415-006-0392-8 |
0.334 |
|
| 2007 |
Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, ... ... Compston A, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Annals of Neurology. 61: 228-36. PMID 17252545 DOI: 10.1002/Ana.21063 |
0.317 |
|
| 2007 |
Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, Cournu-Rebeix I, ... ... Compston A, et al. Corrigendum to "Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans" [J. Neuroimmunol. 179 (2006) 108-116] (DOI:10.1016/j.jneuroim.2006.06.003) Journal of Neuroimmunology. 189: 175-176. DOI: 10.1016/J.Jneuroim.2007.08.003 |
0.307 |
|
| 2006 |
Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, ... ... Compston A, et al. Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans. Journal of Neuroimmunology. 179: 108-16. PMID 16934875 DOI: 10.1016/J.Jneuroim.2006.06.003 |
0.32 |
|
| 2006 |
Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, ... ... Compston A, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Human Molecular Genetics. 15: 2813-24. PMID 16905561 DOI: 10.1093/Hmg/Ddl223 |
0.363 |
|
| 2006 |
Goris A, Yeo TW, Maranian M, Walton A, Ban M, Gray J, Compston A, Sawcer S. Novel Olig 1-coding variants and susceptibility to multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 1296-7. PMID 16820418 DOI: 10.1136/Jnnp.2006.090639 |
0.352 |
|
| 2006 |
Goris A, Maranian M, Walton A, Yeo TW, Ban M, Gray J, Compston A, Sawcer S. No evidence for association of a European-specific chromosome 17 inversion with multiple sclerosis. European Journal of Human Genetics : Ejhg. 14: 1064. PMID 16736032 DOI: 10.1038/Sj.Ejhg.5201665 |
0.31 |
|
| 2006 |
Compston A. Making progress on the natural history of multiple sclerosis. Brain : a Journal of Neurology. 129: 561-3. PMID 16477087 DOI: 10.1093/Brain/Awl034 |
0.363 |
|
| 2006 |
De Jager PL, Sawcer S, Waliszewska A, Farwell L, Wild G, Cohen A, Langelier D, Bitton A, Compston A, Hafler DA, Rioux JD. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis. European Journal of Human Genetics : Ejhg. 14: 317-21. PMID 16391555 DOI: 10.1038/Sj.Ejhg.5201548 |
0.33 |
|
| 2006 |
Sawcer S, Compston A. Multiple sclerosis: light at the end of the tunnel. European Journal of Human Genetics : Ejhg. 14: 257-8. PMID 16391554 DOI: 10.1038/Sj.Ejhg.5201561 |
0.339 |
|
| 2006 |
Roxburgh RH, Sawcer S, Maranian M, Seaman S, Hensiek A, Yeo T, Deans J, Compston A. No evidence of a significant role for CTLA-4 in multiple sclerosis. Journal of Neuroimmunology. 171: 193-7. PMID 16325273 DOI: 10.1016/J.Jneuroim.2005.10.006 |
0.356 |
|
| 2006 |
Traherne JA, Barcellos LF, Sawcer SJ, Compston A, Ramsay PP, Hauser SL, Oksenberg JR, Trowsdale J. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Human Molecular Genetics. 15: 155-61. PMID 16321988 DOI: 10.1093/Hmg/Ddi436 |
0.371 |
|
| 2006 |
Fenoglio C, Galimberti D, Ban M, Maranian M, Scalabrini D, Venturelli E, Piccio L, De Riz M, Yeo TW, Goris A, Gray J, Bresolin N, Scarpini E, Compston A, Sawcer S. SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis. Neuroscience Letters. 394: 92-6. PMID 16257118 DOI: 10.1016/J.Neulet.2005.10.014 |
0.347 |
|
| 2005 |
Ban M, Maranian M, Yeo TW, Gray J, Compston A, Sawcer S. Ultraconserved regions in multiple sclerosis. European Journal of Human Genetics : Ejhg. 13: 998-9. PMID 15986040 DOI: 10.1038/Sj.Ejhg.5201457 |
0.326 |
|
| 2005 |
Ban M, Maranian M, Yeo TW, Gray J, Compston A, Sawcer S. No evidence for association of the protein kinase C alpha gene with multiple sclerosis. Journal of Neurology. 252: 619-20. PMID 15742114 DOI: 10.1007/S00415-005-0706-2 |
0.325 |
|
| 2004 |
Compston A. 'The marvellous harmony of the nervous parts': the origins of multiple sclerosis. Clinical Medicine (London, England). 4: 346-54. PMID 15372896 DOI: 10.7861/Clinmedicine.4-4-346 |
0.35 |
|
| 2003 |
Goertsches R, Villoslada P, Comabella M, Montalban X, Navarro A, de la Concha EG, Arroyo R, Lopez de Munain A, Otaegui D, Palacios R, Perez-Tur J, Jonasdottir A, Benediktsson K, Fossdal R, Sawcer S, ... ... Compston A, et al. A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease. Journal of Neuroimmunology. 143: 124-8. PMID 14575929 DOI: 10.1016/J.Jneuroim.2003.08.026 |
0.365 |
|
| 2003 |
Martins Silva B, Thorlacius T, Benediktsson K, Pereira C, Fossdal R, Jonsson HH, Silva A, Leite I, Cerqueira J, Costa PP, Marta M, Foltynie T, Sawcer S, Compston A, Jonasdottir A. A whole genome association study in multiple sclerosis patients from north Portugal. Journal of Neuroimmunology. 143: 116-9. PMID 14575927 DOI: 10.1016/J.Jneuroim.2003.08.024 |
0.344 |
|
| 2003 |
Bielecki B, Mycko MP, Tronczyńska E, Bieniek M, Sawcer S, Setakis E, Benediktsson K, Compston A, Selmaj KW. A whole genome screen for association in Polish multiple sclerosis patients. Journal of Neuroimmunology. 143: 107-11. PMID 14575925 DOI: 10.1016/J.Jneuroim.2003.08.022 |
0.331 |
|
| 2003 |
Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, ... Compston A, et al. Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients. Journal of Neuroimmunology. 143: 101-6. PMID 14575924 DOI: 10.1016/J.Jneuroim.2003.08.021 |
0.327 |
|
| 2003 |
Liguori M, Sawcer S, Setakis E, Compston A, Giordano M, D'Alfonso S, Mellai M, Malferrari G, Trojano M, Livrea P, De Robertis F, Massacesi L, Repice A, Ballerini C, Biagioli T, et al. A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. Journal of Neuroimmunology. 143: 97-100. PMID 14575923 DOI: 10.1016/J.Jneuroim.2003.08.020 |
0.333 |
|
| 2003 |
Heggarty S, Sawcer S, Hawkins S, McDonnell G, Droogan A, Vandenbroeck K, Hutchinson M, Setakis E, Compston A, Graham C. A genome wide scan for association with multiple sclerosis in a N. Irish case control population. Journal of Neuroimmunology. 143: 93-6. PMID 14575922 DOI: 10.1016/J.Jneuroim.2003.08.019 |
0.342 |
|
| 2003 |
Jonasdottir A, Thorlacius T, Fossdal R, Jonasdottir A, Benediktsson K, Benedikz J, Jonsson HH, Sainz J, Einarsdottir H, Sigurdardottir S, Kristjansdottir G, Sawcer S, Compston A, Stefansson K, Gulcher J. A whole genome association study in Icelandic multiple sclerosis patients with 4804 markers. Journal of Neuroimmunology. 143: 88-92. PMID 14575921 DOI: 10.1016/J.Jneuroim.2003.08.018 |
0.339 |
|
| 2003 |
Rajda C, Bencsik K, Seres E, Jonasdottir A, Foltynie T, Sawcer S, Benediktsson K, Fossdal R, Setakis E, Compston A, Vécsei L. A genome-wide screen for association in Hungarian multiple sclerosis. Journal of Neuroimmunology. 143: 84-7. PMID 14575920 DOI: 10.1016/J.Jneuroim.2003.08.017 |
0.37 |
|
| 2003 |
Weber A, Infante-Duarte C, Sawcer S, Setakis E, Bellmann-Strobl J, Hensiek A, Rueckert S, Schoenemann C, Benediktsson K, Compston A, Zipp F. A genome-wide German screen for linkage disequilibrium in multiple sclerosis. Journal of Neuroimmunology. 143: 79-83. PMID 14575919 DOI: 10.1016/J.Jneuroim.2003.08.016 |
0.364 |
|
| 2003 |
Alizadeh M, Génin E, Babron MC, Birebent B, Cournu-Rebeix I, Yaouanq J, Dréano S, Sawcer S, Compston A, Clanet M, Edan G, Fontaine B, Clerget-Darpoux F, Semana G. Genetic analysis of multiple sclerosis in Europeans: French data. Journal of Neuroimmunology. 143: 74-8. PMID 14575918 DOI: 10.1016/J.Jneuroim.2003.08.015 |
0.342 |
|
| 2003 |
Goris A, Sawcer S, Vandenbroeck K, Carton H, Billiau A, Setakis E, Compston A, Dubois B. New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population. Journal of Neuroimmunology. 143: 65-9. PMID 14575916 DOI: 10.1016/J.Jneuroim.2003.08.013 |
0.345 |
|
| 2003 |
Yeo TW, Roxburgh R, Maranian M, Singlehurst S, Gray J, Hensiek A, Setakis E, Compston A, Sawcer S. Refining the analysis of a whole genome linkage disequilibrium association map: the United Kingdom results. Journal of Neuroimmunology. 143: 53-9. PMID 14575914 DOI: 10.1016/J.Jneuroim.2003.08.011 |
0.332 |
|
| 2003 |
Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano-Richiardi P, Cocco E, Murru R, Hillert J, Compston A, Sawcer S. Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. Journal of Neuroimmunology. 143: 31-8. PMID 14575911 DOI: 10.1016/J.Jneuroim.2003.08.008 |
0.321 |
|
| 2003 |
Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 872-7. PMID 12810770 DOI: 10.1136/Jnnp.74.7.872 |
0.578 |
|
| 2002 |
Goedde R, Sawcer S, Boehringer S, Miterski B, Sindern E, Haupts M, Schimrigk S, Compston A, Epplen JT. A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers. Human Genetics. 111: 270-7. PMID 12215840 DOI: 10.1007/S00439-002-0801-8 |
0.367 |
|
| 2002 |
Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A, Coraddu F, Roxburgh R, Sawcer D, Gray J, Deans J, Goodfellow PN, Walker N, Clayton D, Compston A. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain : a Journal of Neurology. 125: 1337-47. PMID 12023322 DOI: 10.1093/Brain/Awf143 |
0.318 |
|
| 2001 |
Coraddu F, Sawcer S, D'Alfonso S, Lai M, Hensiek A, Solla E, Broadley S, Mancosu C, Pugliatti M, Marrosu MG, Compston A. A genome screen for multiple sclerosis in Sardinian multiplex families. European Journal of Human Genetics : Ejhg. 9: 621-6. PMID 11528508 DOI: 10.1038/Sj.Ejhg.5200680 |
0.334 |
|
| 2000 |
Feakes R, Sawcer S, Smillie B, Chataway J, Broadley S, Compston A. No evidence for the involvement of interleukin 2 or the immunoglobulin heavy chain gene cluster in determining genetic susceptibility to multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 68: 679. PMID 10836865 DOI: 10.1136/Jnnp.68.5.679 |
0.314 |
|
| 2000 |
Compston A. The genetics of multiple sclerosis. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 38: 133-5. PMID 10834400 DOI: 10.1515/Cclm.2000.020 |
0.315 |
|
| 2000 |
Feakes R, Sawcer S, Broadley S, Coraddu F, Roxburgh R, Gray J, Clayton D, Compston A. Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis. Journal of Neuroimmunology. 105: 96-101. PMID 10713369 DOI: 10.1016/S0165-5728(00)00203-4 |
0.336 |
|
| 2000 |
Stangel M, Compston A, Scolding NJ. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg"). Journal of Neuroimmunology. 103: 195-201. PMID 10696915 DOI: 10.1016/S0165-5728(99)00241-6 |
0.305 |
|
| 1999 |
Compston A. The genetic epidemiology of multiple sclerosis. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 354: 1623-34. PMID 10603615 DOI: 10.1098/Rstb.1999.0507 |
0.349 |
|
| 1999 |
Coles AJ, Wing M, Smith S, Coraddu F, Greer S, Taylor C, Weetman A, Hale G, Chatterjee VK, Waldmann H, Compston A. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet. 354: 1691-5. PMID 10568572 DOI: 10.1016/S0140-6736(99)02429-0 |
0.312 |
|
| 1999 |
Chataway J, Sawcer S, Sherman D, Hobart M, Fernie B, Coraddu F, Feakes R, Broadley S, Gray J, Jones HB, Clayton D, Goodfellow PN, Compston A. No evidence for association of multiple sclerosis with the complement factors C6 and C7. Journal of Neuroimmunology. 99: 150-6. PMID 10496188 DOI: 10.1016/S0165-5728(99)00054-5 |
0.311 |
|
| 1999 |
Coles AJ, Wing MG, Molyneux P, Paolillo A, Davie CM, Hale G, Miller D, Waldmann H, Compston A. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Annals of Neurology. 46: 296-304. PMID 10482259 DOI: 10.1002/1531-8249(199909)46:3<296::Aid-Ana4>3.0.Co;2-# |
0.342 |
|
| 1999 |
Chataway J, Sawcer S, Feakes R, Coraddu F, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A. A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis. Journal of Neuroimmunology. 98: 208-13. PMID 10430054 DOI: 10.1016/S0165-5728(99)00089-2 |
0.334 |
|
| 1999 |
Chataway J, Sawcer S, Coraddu F, Feakes R, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A. Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis. Neurogenetics. 2: 91-6. PMID 10369884 DOI: 10.1007/S100480050058 |
0.354 |
|
| 1999 |
Stangel M, Compston A, Scolding NJ. Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes. Journal of Neuroimmunology. 96: 228-33. PMID 10337921 DOI: 10.1016/S0165-5728(99)00035-1 |
0.315 |
|
| 1999 |
Compston A. Provision of treatment for multiple sclerosis. Lancet. 353: 1710-1. PMID 10335817 DOI: 10.1016/S0140-6736(05)77022-7 |
0.307 |
|
| 1998 |
Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain : a Journal of Neurology. 121: 2221-8. PMID 9874475 DOI: 10.1093/Brain/121.12.2221 |
0.329 |
|
| 1998 |
Compston A. Future options for therapies to limit damage and enhance recovery. Seminars in Neurology. 18: 405-14. PMID 9817543 DOI: 10.1055/S-2008-1040890 |
0.301 |
|
| 1998 |
Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain : a Journal of Neurology. 121: 1869-87. PMID 9798743 DOI: 10.1093/Brain/121.10.1869 |
0.322 |
|
| 1997 |
Compston A. Remyelination in multiple sclerosis: a challenge for therapy. The 1996 European Charcot Foundation Lecture. Multiple Sclerosis (Houndmills, Basingstoke, England). 3: 51-70. PMID 9291155 DOI: 10.1177/135245859700300201 |
0.302 |
|
| 1996 |
Compston A. Remyelination of the central nervous system. Multiple Sclerosis (Houndmills, Basingstoke, England). 1: 388-92. PMID 9345424 DOI: 10.1177/135245859600100622 |
0.302 |
|
| 1996 |
Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genetics. 13: 464-8. PMID 8696343 DOI: 10.1038/Ng0896-464 |
0.343 |
|
| 1994 |
Compston A. Future prospects for the management of multiple sclerosis Annals of Neurology. 36. PMID 8017879 DOI: 10.1002/Ana.410360736 |
0.312 |
|
| 1994 |
Compston A. The epidemiology of multiple sclerosis: principles, achievements, and recommendations. Annals of Neurology. 36: S211-7. PMID 7998790 DOI: 10.1002/Ana.410360808 |
0.346 |
|
| 1993 |
Compston A. Inflammation and the brain. Molecular and Chemical Neuropathology. 19: 47-64. PMID 8363707 DOI: 10.1007/Bf03160168 |
0.339 |
|
| 1991 |
Compston A, Scolding N, Wren D, Noble M. The pathogenesis of demyelinating disease: insights from cell biology Trends in Neurosciences. 14: 175-182. PMID 1713717 DOI: 10.1016/0166-2236(91)90099-G |
0.325 |
|
| 1990 |
Compston A. Multiple sclerosis: A Conceptual Reappraisal with Heuristic Implications Journal of Neurology, Neurosurgery, and Psychiatry. 53: 450-451. DOI: 10.1136/Jnnp.53.5.450-B |
0.351 |
|
| 1989 |
Scolding N, Linington C, Compston A. Immune mechanisms in the pathogenesis of demyelinating diseases. Autoimmunity. 4: 131-142. PMID 2491638 DOI: 10.3109/08916938909034368 |
0.314 |
|
| 1982 |
Compston A, Howard S. HLA typing in multiple sclerosis. The Lancet. 320: 661. PMID 6125796 DOI: 10.1016/S0140-6736(82)92762-3 |
0.31 |
|
| 1981 |
Compston A. Multiple sclerosis in the Orkneys. The Lancet. 318: 98. PMID 6113476 DOI: 10.1016/S0140-6736(81)90454-2 |
0.352 |
|
| Show low-probability matches. |